(Q69506858)

English

Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group

scientific article published on 01 May 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference

based on heuristic

inferred from title

multiple sclerosis

1 reference

based on heuristic

inferred from title

language of work or name

0 references

publication date

1 May 1989

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

52

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

566-574

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Inhibition of Prostaglandin Synthetase in Brain explains the Anti-pyretic Activity of Paracetamol (4-Acetamidophenol)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for the clinical diagnosis of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfer factor treatment of multiple sclerosis. A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term transfer-factor treatment for multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind trial of transfer factor vs placebo in multiple sclerosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A diagnostic index of active demyelination: Myelin basic protein in cerebrospinal fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecal interferon in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zinc and Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic effects of interferon administered intrathecally

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of cloned interferon alpha 2 in normal volunteers: febrile reactions and changes in circulating corticosteroids and trace metals

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indomethacin Reduces the Side Effects of Intrathecal Interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple Sclerosis as a Disease of Immune Regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic alpha-interferon therapy of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons and natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecal interferon in the treatment of multiple sclerosis. Patient follow-up.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enervating illness and Epstein-Barr virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfer factor therapy in multiple sclerosis: a three-year prospective double-blind clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variability on serial testing of pattern reversal visual evoked potential latencies from full-field, half-field and foveal stimulation in control subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normal temporal variability of the P100

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virus interference. I. The interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfer-factor therapy in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2659737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.52.5.566

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2659737%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69506858&oldid=1684126429"